| Feasibility and therapeutic potential of 177Lu–fibroblast activation protein inhibitor–46 for patients with relapsed or refractory cancers: a preliminary study M Assadi, SJ Rekabpour, E Jafari, GA Divband, B Nikkholgh, H Amini, ... Clinical nuclear medicine 46 (11), e523-e530, 2021 | 75 | 2021 |
| Theranostic approach in breast cancer: a treasured tailor for future oncology N Jokar, I Velikyan, H Ahmadzadehfar, SJ Rekabpour, E Jafari, HH Ting, ... Clinical Nuclear Medicine 46 (8), e410-e420, 2021 | 41 | 2021 |
| Effect of pulsed electromagnetic field on mandibular fracture healing: A randomized control trial,(RCT) H Mohajerani, F Tabeie, F Vossoughi, E Jafari, M Assadi Journal of stomatology, oral and maxillofacial surgery 120 (5), 390-396, 2019 | 36 | 2019 |
| An update on PET-based molecular imaging in neuro-oncology: challenges and implementation for a precision medicine approach in cancer care H Shooli, H Dadgar, YXJ Wáng, MS Vafaee, SR Kashuk, R Nemati, ... Quantitative imaging in medicine and surgery 9 (9), 1597, 2019 | 27 | 2019 |
| 177Lu-PSMA and 177Lu-DOTATATE Therapy in a patient with metastatic castration-resistant prostate cancer and neuroendocrine differentiation M Assadi, E Pirayesh, SJ Rekabpour, F Zohrabi, E Jafari, I Nabipour, ... Clinical nuclear medicine 44 (12), 978-980, 2019 | 24 | 2019 |
| The evaluation of protective and mitigating effects of vitamin C against side effects induced by radioiodine therapy E Jafari, M Alavi, F Zal Radiation and Environmental Biophysics 57, 233-240, 2018 | 22 | 2018 |
| Assessment of the prevalence of diabetic gastroparesis and validation of gastric emptying scintigraphy for diagnosis Z Alipour, F Khatib, SM Tabib, H Javadi, E Jafari, L Aghaghazvini, ... Molecular Imaging and Radionuclide Therapy 26 (1), 17, 2017 | 22 | 2017 |
| Potential application of lutetium-177-labeled prostate-specific membrane antigen-617 radioligand therapy for metastatic castration-resistant prostate cancer in a limited … M Assadi, S Rezaei, E Jafari, SJ Rekabpour, M Ravanbod, F Zohrabi, ... World Journal of Nuclear Medicine 19 (01), 15-20, 2020 | 21 | 2020 |
| An aggressive functioning pituitary adenoma treated with peptide receptor radionuclide therapy M Assadi, R Nemati, H Shooli, SJ Rekabpour, I Nabipour, E Jafari, ... European Journal of Nuclear Medicine and Molecular Imaging 47, 1015-1016, 2020 | 19 | 2020 |
| Feasibility and therapeutic potential of combined peptide receptor radionuclide therapy with intensive chemotherapy for pediatric patients with relapsed or refractory … G Fathpour, E Jafari, A Hashemi, H Dadgar, M Shahriari, S Zareifar, ... Clinical Nuclear Medicine 46 (7), 540-548, 2021 | 14 | 2021 |
| Application of [68Ga]PSMA PET/CT in Diagnosis and Management of Prostate Cancer Patients H Dadgar, F Emami, N Norouzbeigi, MS Vafaee, E Jafari, ... Molecular Imaging and Biology 22, 1062-1069, 2020 | 14 | 2020 |
| Theranostics in brain tumors H Shooli, R Nemati, H Ahmadzadehfar, M Aboian, E Jafari, N Jokar, ... PET clinics 16 (3), 397-418, 2021 | 11 | 2021 |
| Predictive and prognostic potential of pretreatment 68Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer treated with 177Lu-PSMA M Assadi, R Manafi-Farid, E Jafari, A Keshavarz, GA Divband, MM Moradi, ... Frontiers in Oncology 12, 1066926, 2022 | 10 | 2022 |
| An overview on prostate-specific membrane antigen uptake in malignancies other than prostate cancer: A pictorial essay E Jafari, H Ahmadzadehfar, H Dadgar, M Assadi World Journal of Nuclear Medicine 19 (03), 260-265, 2020 | 9 | 2020 |
| Feasibility and therapeutic potential of the 68Ga/177Lu-DOTATATE theranostic pair in patients with metastatic medullary thyroid carcinoma H Dadgar, E Jafari, H Ahmadzadehfar, SJ Rekabpour, MR Ravanbod, ... Annales d'Endocrinologie 84 (1), 45-51, 2023 | 8 | 2023 |
| Feasibility and therapeutic potential of peptide receptor radionuclide therapy for high-grade gliomas R Nemati, H Shooli, SJ Rekabpour, H Ahmadzadehfar, E Jafari, ... Clinical nuclear medicine 46 (5), 389-395, 2021 | 7 | 2021 |
| Somatostatin receptor scintigraphy in a patient with myocarditis A Amini, F Dehdar, E Jafari, A Gholamrezanezhad, M Assadi Molecular imaging and radionuclide therapy 30 (1), 50, 2021 | 7 | 2021 |
| Differential privacy preserved federated transfer learning for multi-institutional 68Ga-PET image artefact detection and disentanglement I Shiri, Y Salimi, M Maghsudi, E Jenabi, S Harsini, B Razeghi, S Mostafaei, ... European journal of nuclear medicine and molecular imaging 51 (1), 40-53, 2023 | 6 | 2023 |
| Peptide receptor radionuclide therapy with 177Lu-DOTATATE in a case of concurrent neuroendocrine tumors and meningioma: achieving two things in a single action M Assadi, SJ Rekabpour, A Amini, H Dadgar, R Nemati, ... Molecular Imaging and Radionuclide Therapy 30 (2), 107, 2021 | 6 | 2021 |
| Cardiotoxicity and cardiac monitoring following the use of radiotheranostics agents including 177Lu-PSMA for prostate cancer and 177Lu-DOTATATE for neuroendocrine tumors E Jafari, AL Amini, H Ahmadzadehfar, D Bagheri, M Assadi Nuklearmedizin-NuclearMedicine 60 (02), 99-105, 2021 | 6 | 2021 |
Majid Assadi, MD,MSc(Adv.Onc.),FAS...Bushehr Medical Center HospitalGeverifieerd e-mailadres voor bpums.ac.ir
